| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.761 | 0.003 | 0.924 | Non-steroidal antiinflammatory agent | 0.598 0.004 DBMET00166 0.759 0.003 DBMET00167 0.61 0.004 DBMET01271 0.774 0.003 DBMET01272 0.924 0.002 DBMET01273 | DBMET01273 | |
| 0.692 | 0.003 | 0.692 | Cyclooxygenase inhibitor | 0.624 0.004 DBMET00166 0.643 0.004 DBMET00167 0.576 0.004 DBMET01271 0.626 0.004 DBMET01272 0.483 0.005 DBMET01273 | ||
| 0.652 | 0.003 | 0.652 | Cyclooxygenase 2 inhibitor | 0.578 0.004 DBMET00166 0.597 0.004 DBMET00167 0.525 0.004 DBMET01271 0.578 0.004 DBMET01272 0.435 0.005 DBMET01273 | ||
| 0.546 | 0.005 | 0.546 | Cyclooxygenase 1 inhibitor | 0.464 0.005 DBMET00166 0.511 0.005 DBMET00167 0.42 0.006 DBMET01271 0.488 0.005 DBMET01272 0.379 0.008 DBMET01273 | ||
| 0.589 | 0.057 | 0.791 | Antiinflammatory | 0.53 0.076 DBMET00166 0.622 0.048 DBMET00167 0.428 0.122 DBMET01271 0.61 0.051 DBMET01272 0.791 0.017 DBMET01273 | DBMET01273 | |
| 0.461 | 0.04 | 0.649 | Toll-Like receptor 7 agonist | 0.649 0.012 DBMET00166 0.538 0.025 DBMET00167 0.572 0.021 DBMET01271 0.403 0.059 DBMET01272 0.37 0.072 DBMET01273 | DBMET00166 | |
| 0.454 | 0.042 | 0.641 | Toll-Like receptor agonist | 0.641 0.013 DBMET00166 0.533 0.026 DBMET00167 0.564 0.021 DBMET01271 0.395 0.062 DBMET01272 0.395 0.062 DBMET01273 | DBMET00166 | |
| 0.432 | 0.031 | 0.432 | Nootropic | 0.368 0.048 DBMET00166 0.362 0.05 DBMET00167 0.319 0.065 DBMET01272 | ||
| 0.429 | 0.043 | 0.429 | MAP kinase kinase 6 inhibitor | 0.417 0.049 DBMET00166 0.306 0.129 DBMET00167 0.33 0.109 DBMET01271 0.34 0.101 DBMET01272 | ||
| 0.434 | 0.054 | 0.488 | Antiobesity | 0.488 0.04 DBMET00167 0.239 0.167 DBMET01271 0.429 0.055 DBMET01272 0.455 0.048 DBMET01273 | DBMET00167 | |
| 0.438 | 0.069 | 0.438 | Analgesic | 0.282 0.156 DBMET00166 0.335 0.117 DBMET00167 0.39 0.089 DBMET01272 | ||
| 0.406 | 0.088 | 0.753 | Cyclophilin D inhibitor | 0.48 0.056 DBMET00166 0.535 0.041 DBMET00167 0.432 0.074 DBMET01271 0.536 0.041 DBMET01272 0.753 0.009 DBMET01273 | DBMET01273 | |
| 0.32 | 0.03 | 0.32 | EphB2 antagonist | 0.181 0.102 DBMET00166 0.211 0.08 DBMET00167 0.224 0.072 DBMET01272 | ||
| 0.303 | 0.014 | 0.39 | Heat shock protein 90 alpha antagonist | 0.39 0.005 DBMET00166 0.191 0.055 DBMET00167 0.218 0.04 DBMET01271 0.213 0.042 DBMET01272 | DBMET00166 | |
| 0.328 | 0.041 | 0.328 | Potassium channel (Voltage-sensitive) blocker | 0.174 0.117 DBMET00167 | ||
| 0.294 | 0.012 | 0.294 | MAP kinase 9 inhibitor | 0.143 0.04 DBMET00166 0.156 0.035 DBMET00167 0.091 0.071 DBMET01271 0.159 0.034 DBMET01272 | ||
| 0.289 | 0.014 | 0.329 | Insulin secretagoues | 0.278 0.015 DBMET00166 0.247 0.02 DBMET00167 0.271 0.016 DBMET01271 0.329 0.01 DBMET01272 0.318 0.01 DBMET01273 | DBMET01272 | |
| 0.319 | 0.044 | 0.319 | HERG channel blocker | 0.141 0.14 DBMET00166 0.174 0.107 DBMET00167 | ||
| 0.271 | 0.007 | 0.271 | Aurora-C kinase inhibitor | 0.222 0.014 DBMET00166 0.266 0.008 DBMET00167 0.216 0.016 DBMET01271 0.256 0.009 DBMET01272 0.134 0.074 DBMET01273 | ||
| 0.263 | 0.007 | 0.603 | Phosphodiesterase IV inhibitor | 0.556 0.003 DBMET00166 0.315 0.005 DBMET00167 0.603 0.003 DBMET01271 0.201 0.013 DBMET01272 | DBMET01271 | |
| 0.314 | 0.066 | 0.314 | 5 Hydroxytryptamine release stimulant | 0.183 0.137 DBMET00166 0.311 0.066 DBMET00167 0.182 0.138 DBMET01271 0.183 0.137 DBMET01272 | ||
| 0.241 | 0.005 | 0.369 | Phosphodiesterase 4B inhibitor | 0.369 0.004 DBMET00166 0.301 0.005 DBMET00167 0.349 0.004 DBMET01271 0.179 0.009 DBMET01272 | DBMET00166 | |
| 0.23 | 0.008 | 0.23 | Hedgehog signaling inhibitor | 0.105 0.056 DBMET00166 0.177 0.015 DBMET00167 0.123 0.038 DBMET01272 0.094 0.075 DBMET01273 | ||
| 0.255 | 0.035 | 0.255 | LIM domain kinase 1 inhibitor | 0.139 0.11 DBMET00167 0.161 0.087 DBMET01272 | ||
| 0.224 | 0.006 | 0.224 | Pregnane X receptor agonist | 0.171 0.025 DBMET00166 0.187 0.015 DBMET00167 0.146 0.06 DBMET01271 0.177 0.021 DBMET01272 | ||
| 0.235 | 0.024 | 0.235 | Activin receptor-like kinase 2 inhibitor | 0.173 0.051 DBMET00167 0.118 0.099 DBMET01272 | ||
| 0.213 | 0.012 | 0.213 | Activin receptor-like kinase 4 inhibitor | 0.11 0.067 DBMET00166 0.112 0.063 DBMET00167 0.108 0.069 DBMET01272 | ||
| 0.28 | 0.079 | 0.28 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.229 0.127 DBMET00167 0.244 0.112 DBMET01272 | ||
| 0.214 | 0.034 | 0.241 | Interleukin 6 antagonist | 0.241 0.025 DBMET00166 0.188 0.048 DBMET00167 0.21 0.035 DBMET01271 0.181 0.054 DBMET01272 0.212 0.035 DBMET01273 | DBMET00166 | |
| 0.195 | 0.017 | 0.195 | MAP kinase 8 inhibitor | 0.116 0.046 DBMET00166 0.129 0.038 DBMET00167 0.094 0.068 DBMET01271 0.135 0.035 DBMET01272 | ||
| 0.181 | 0.013 | 0.256 | Phosphodiesterase 4D inhibitor | 0.256 0.007 DBMET00166 0.136 0.023 DBMET00167 0.213 0.01 DBMET01271 0.157 0.018 DBMET01272 | DBMET00166 | |
| 0.197 | 0.031 | 0.197 | Sodium channel (voltage-gated) blocker | 0.177 0.039 DBMET00167 0.171 0.042 DBMET01272 | ||
| 0.241 | 0.076 | 0.251 | Dyrk kinase inhibitor | 0.203 0.097 DBMET00167 0.251 0.071 DBMET01272 | DBMET01272 | |
| 0.163 | 0.004 | 0.164 | G protein-coupled receptor agonist | 0.062 0.012 DBMET00166 0.164 0.004 DBMET00167 0.062 0.012 DBMET01271 0.073 0.009 DBMET01272 | DBMET00167 | |
| 0.178 | 0.02 | 0.184 | Potassium channel (Ca-activated) activator | 0.095 0.06 DBMET00166 0.099 0.056 DBMET00167 0.184 0.018 DBMET01272 | DBMET01272 | |
| 0.164 | 0.006 | 0.183 | Phosphodiesterase 4C inhibitor | 0.183 0.005 DBMET00166 0.124 0.01 DBMET00167 0.148 0.007 DBMET01271 0.116 0.012 DBMET01272 | DBMET00166 | |
| 0.162 | 0.005 | 0.162 | Liver X receptor agonist | 0.103 0.007 DBMET00166 0.143 0.005 DBMET00167 0.096 0.008 DBMET01271 0.134 0.005 DBMET01272 0.047 0.026 DBMET01273 | ||
| 0.196 | 0.038 | 0.196 | Cyclin-dependent kinase 8 inhibitor | 0.142 0.087 DBMET00166 0.162 0.068 DBMET00167 0.171 0.06 DBMET01272 | ||
| 0.158 | 0.004 | 0.158 | Liver X receptor antagonist | 0.099 0.005 DBMET00166 0.154 0.004 DBMET00167 0.1 0.005 DBMET01271 0.137 0.004 DBMET01272 0.035 0.018 DBMET01273 | ||
| 0.155 | 0.003 | 0.155 | Corticotropin releasing factor 2 receptor antagonist | 0.079 0.018 DBMET00166 0.069 0.03 DBMET00167 0.063 0.039 DBMET01272 | ||
| 0.154 | 0.006 | 0.178 | Bromodomain-containing protein 4 inhibitor | 0.178 0.005 DBMET00166 0.093 0.015 DBMET00167 0.06 0.032 DBMET01271 0.069 0.025 DBMET01272 | DBMET00166 | |
| 0.165 | 0.017 | 0.165 | Janus tyrosine kinase 2 inhibitor | 0.117 0.03 DBMET00167 0.081 0.047 DBMET01272 | ||
| 0.155 | 0.019 | 0.155 | ALK inhibitor | 0.078 0.062 DBMET00166 0.104 0.038 DBMET00167 0.099 0.041 DBMET01272 | ||
| 0.215 | 0.082 | 0.351 | Peptidyltransferase inhibitor | 0.189 0.113 DBMET00166 0.215 0.082 DBMET00167 0.191 0.111 DBMET01271 0.232 0.065 DBMET01272 0.351 0.012 DBMET01273 | DBMET01273 | |
| 0.208 | 0.077 | 0.208 | MAP kinase kinase 2 inhibitor | 0.143 0.128 DBMET01272 | ||
| 0.225 | 0.096 | 0.225 | Tyrosine 3 hydroxylase inhibitor | 0.201 0.134 DBMET00166 0.212 0.115 DBMET00167 0.189 0.157 DBMET01271 0.224 0.097 DBMET01272 | ||
| 0.131 | 0.004 | 0.131 | Liver X receptor beta agonist | 0.038 0.017 DBMET00166 0.131 0.004 DBMET00167 0.041 0.014 DBMET01271 0.103 0.005 DBMET01272 | ||
| 0.152 | 0.028 | 0.152 | Ca(v)2.2 blocker | |||
| 0.209 | 0.086 | 0.209 | Potassium channel blocker | |||
| 0.174 | 0.052 | 0.174 | CDC-like kinase 1 inhibitor | 0.111 0.105 DBMET00167 0.164 0.059 DBMET01272 | ||
| 0.168 | 0.047 | 0.278 | Phosphodiesterase inhibitor | 0.278 0.018 DBMET00166 0.19 0.038 DBMET00167 0.244 0.024 DBMET01271 | DBMET00166 | |
| 0.133 | 0.016 | 0.133 | Bromodomain-containing protein 2 inhibitor | 0.088 0.06 DBMET00167 | ||
| 0.192 | 0.075 | 0.192 | Focal adhesion kinase 2 inhibitor | |||
| 0.12 | 0.004 | 0.12 | Glucose-dependent insulinotropic receptor agonist | 0.055 0.009 DBMET00166 0.093 0.004 DBMET00167 0.041 0.017 DBMET01271 0.039 0.018 DBMET01272 | ||
| 0.14 | 0.023 | 0.14 | Leucine-rich repeat kinase 2 inhibitor | 0.089 0.05 DBMET00167 | ||
| 0.15 | 0.034 | 0.176 | Interleukin 8 antagonist | 0.123 0.058 DBMET00166 0.111 0.075 DBMET00167 0.101 0.095 DBMET01271 0.176 0.021 DBMET01272 | DBMET01272 | |
| 0.126 | 0.011 | 0.126 | Transforming growth factor antagonist | 0.063 0.059 DBMET00167 | ||
| 0.126 | 0.012 | 0.316 | Phosphodiesterase 4A inhibitor | 0.316 0.005 DBMET00166 0.164 0.009 DBMET00167 0.247 0.005 DBMET01271 0.079 0.02 DBMET01272 | DBMET00166 | |
| 0.133 | 0.019 | 0.133 | MAP kinase 10 inhibitor | 0.079 0.052 DBMET00167 0.08 0.051 DBMET01272 | ||
| 0.117 | 0.003 | 0.159 | Liver X receptor beta antagonist | 0.054 0.007 DBMET00166 0.159 0.003 DBMET00167 0.07 0.005 DBMET01271 0.128 0.003 DBMET01272 | DBMET00167 | |
| 0.116 | 0.005 | 0.13 | Liver X receptor alpha agonist | 0.05 0.019 DBMET00166 0.13 0.004 DBMET00167 0.057 0.014 DBMET01271 0.099 0.005 DBMET01272 | DBMET00167 | |
| 0.168 | 0.057 | 0.236 | Heat shock protein 90 antagonist | 0.236 0.025 DBMET00166 0.125 0.106 DBMET01271 | DBMET00166 | |
| 0.161 | 0.05 | 0.161 | Sodium channel blocker | 0.134 0.071 DBMET00167 0.123 0.081 DBMET01272 | ||
| 0.124 | 0.016 | 0.124 | Nav1.7 sodium channel blocker | 0.113 0.019 DBMET00167 0.067 0.047 DBMET01272 | ||
| 0.2 | 0.092 | 0.223 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.174 0.11 DBMET00167 0.223 0.08 DBMET01272 | DBMET01272 | |
| 0.131 | 0.023 | 0.131 | Janus tyrosine kinase 3 inhibitor | 0.087 0.04 DBMET00167 0.069 0.053 DBMET01272 | ||
| 0.19 | 0.084 | 0.19 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.139 0.13 DBMET00167 0.188 0.086 DBMET01272 | ||
| 0.105 | 0.005 | 0.105 | Transcription factor RelA inhibitor | 0.091 0.01 DBMET00166 0.063 0.046 DBMET00167 0.062 0.049 DBMET01271 0.066 0.037 DBMET01272 | ||
| 0.162 | 0.064 | 0.162 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.141 0.082 DBMET00167 0.157 0.068 DBMET01272 | ||
| 0.125 | 0.028 | 0.138 | ABCA1 expression enhancer | 0.093 0.06 DBMET00166 0.119 0.032 DBMET00167 0.091 0.064 DBMET01271 0.138 0.021 DBMET01272 | DBMET01272 | |
| 0.193 | 0.096 | 0.193 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.145 | 0.048 | 0.145 | Aurora-B kinase inhibitor | 0.097 0.086 DBMET00167 | ||
| 0.114 | 0.021 | 0.114 | Focal adhesion kinase 1 inhibitor | 0.085 0.044 DBMET00166 0.091 0.038 DBMET00167 0.088 0.041 DBMET01272 | ||
| 0.249 | 0.155 | 0.249 | GABA C receptor rho-3 antagonist | |||
| 0.095 | 0.004 | 0.1 | Liver X receptor alpha antagonist | 0.059 0.005 DBMET00166 0.1 0.004 DBMET00167 0.063 0.005 DBMET01271 0.081 0.004 DBMET01272 0.031 0.017 DBMET01273 | DBMET00167 | |
| 0.133 | 0.045 | 0.133 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.149 | 0.061 | 0.161 | MAP3K9 inhibitor | 0.161 0.046 DBMET00167 0.119 0.117 DBMET01271 0.148 0.064 DBMET01272 | DBMET00167 | |
| 0.133 | 0.048 | 0.133 | Aurora-A kinase inhibitor | |||
| 0.114 | 0.029 | 0.114 | I kappa B kinase inhibitor | 0.093 0.045 DBMET00167 | ||
| 0.095 | 0.011 | 0.095 | Transforming growth factor beta 1 antagonist | |||
| 0.094 | 0.011 | 0.094 | MAP kinase kinase 9 inhibitor | 0.059 0.033 DBMET00167 0.055 0.04 DBMET01272 | ||
| 0.106 | 0.025 | 0.106 | Tyk2 inhibitor | 0.079 0.037 DBMET00167 | ||
| 0.142 | 0.063 | 0.197 | Interleukin 1 antagonist | 0.113 0.1 DBMET00167 0.197 0.034 DBMET01272 | DBMET01272 | |
| 0.086 | 0.009 | 0.092 | DNA helicase inhibitor | 0.079 0.012 DBMET00166 0.082 0.01 DBMET00167 0.076 0.013 DBMET01271 0.092 0.007 DBMET01272 0.065 0.021 DBMET01273 | DBMET01272 | |
| 0.122 | 0.045 | 0.122 | Cyclin-dependent kinase 9 inhibitor | 0.111 0.052 DBMET00166 0.092 0.073 DBMET00167 0.092 0.073 DBMET01271 | ||
| 0.077 | 0.002 | 0.117 | CC chemokine 9 receptor antagonist | 0.117 0.001 DBMET00166 0.033 0.003 DBMET00167 0.051 0.003 DBMET01271 0.049 0.003 DBMET01272 | DBMET00166 | |
| 0.09 | 0.016 | 0.126 | CC chemokine 2 receptor antagonist | 0.067 0.027 DBMET00167 0.126 0.009 DBMET01272 | DBMET01272 | |
| 0.098 | 0.024 | 0.098 | I kappa B kinase 1 inhibitor | 0.064 0.057 DBMET00166 0.067 0.052 DBMET00167 | ||
| 0.083 | 0.01 | 0.083 | Aldosterone antagonist | 0.047 0.034 DBMET00166 0.052 0.027 DBMET01272 | ||
| 0.148 | 0.077 | 0.159 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.159 0.057 DBMET01272 | DBMET01272 | |
| 0.083 | 0.013 | 0.083 | Glutamate (mGluR5) antagonist | |||
| 0.138 | 0.069 | 0.138 | Cyclin-dependent kinase 7 inhibitor | 0.126 0.08 DBMET00167 | ||
| 0.129 | 0.061 | 0.129 | TRKA antagonist | 0.111 0.076 DBMET00167 | ||
| 0.096 | 0.03 | 0.096 | Cannabinoid receptor antagonist | |||
| 0.137 | 0.073 | 0.137 | Cytokine production inhibitor | |||
| 0.142 | 0.079 | 0.164 | MAP kinase kinase 4 inhibitor | 0.144 0.075 DBMET00167 0.164 0.04 DBMET01272 | DBMET01272 | |
| 0.166 | 0.103 | 0.176 | I kappa B kinase epsilon inhibitor | 0.176 0.093 DBMET01272 | DBMET01272 | |
| 0.142 | 0.079 | 0.49 | Hemostatic | 0.131 0.094 DBMET00167 0.165 0.052 DBMET01272 0.49 0.004 DBMET01273 | DBMET01273 | |
| 0.098 | 0.037 | 0.106 | Porphobilinogen synthase inhibitor | 0.075 0.052 DBMET00167 0.106 0.033 DBMET01272 | DBMET01272 | |
| 0.128 | 0.067 | 0.193 | Glutamate receptor antagonist | 0.193 0.028 DBMET01272 | DBMET01272 | |
| 0.088 | 0.028 | 0.088 | MAP kinase kinase 8 inhibitor | 0.073 0.041 DBMET00167 0.07 0.045 DBMET01272 | ||
| 0.133 | 0.075 | 0.133 | Toll-Like receptor 9 antagonist | |||
| 0.093 | 0.036 | 0.093 | Rho-associated kinase I inhibitor | 0.09 0.038 DBMET00166 | ||
| 0.078 | 0.024 | 0.078 | I kappa B kinase 2 inhibitor | 0.06 0.047 DBMET00167 | ||
| 0.07 | 0.015 | 0.074 | Smo receptor antagonist | 0.074 0.014 DBMET00167 | DBMET00167 | |
| 0.187 | 0.132 | 0.19 | Cardiotonic | 0.19 0.128 DBMET00167 0.166 0.157 DBMET01272 | DBMET00167 | |
| 0.128 | 0.074 | 0.128 | Toll-Like receptor antagonist | 0.115 0.092 DBMET00167 | ||
| 0.084 | 0.031 | 0.084 | Secretase beta inhibitor | |||
| 0.123 | 0.071 | 0.123 | MAP kinase kinase inhibitor | 0.123 0.071 DBMET00167 | ||
| 0.122 | 0.069 | 0.152 | Sphingosine 1-phosphate receptor 4 antagonist | 0.152 0.032 DBMET00166 0.111 0.092 DBMET00167 0.118 0.076 DBMET01271 0.126 0.063 DBMET01272 | DBMET00166 | |
| 0.128 | 0.076 | 0.128 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.079 | 0.028 | 0.079 | Cannabinoid CB1 receptor antagonist | |||
| 0.057 | 0.006 | 0.057 | ATR kinase inhibitor | 0.031 0.028 DBMET00166 0.036 0.017 DBMET00167 | ||
| 0.089 | 0.04 | 0.089 | Rho-associated kinase inhibitor | 0.069 0.056 DBMET00166 | ||
| 0.056 | 0.007 | 0.056 | Cathepsin F inhibitor | 0.054 0.009 DBMET00166 0.051 0.011 DBMET00167 0.05 0.013 DBMET01271 0.053 0.01 DBMET01272 0.041 0.031 DBMET01273 | ||
| 0.089 | 0.042 | 0.089 | Glutamate (mGluR) antagonist | |||
| 0.206 | 0.16 | 0.352 | Caspase 3 stimulant | 0.204 0.164 DBMET00167 0.352 0.058 DBMET01273 | DBMET01273 | |
| 0.084 | 0.038 | 0.084 | Protein kinase B beta inhibitor | |||
| 0.106 | 0.061 | 0.112 | MAP kinase kinase kinase inhibitor | 0.112 0.056 DBMET00166 | DBMET00166 | |
| 0.117 | 0.073 | 0.117 | MAP kinase 12 inhibitor | |||
| 0.07 | 0.026 | 0.078 | GABA A receptor antagonist | 0.057 0.033 DBMET00166 0.074 0.024 DBMET00167 0.078 0.022 DBMET01271 0.058 0.032 DBMET01272 | DBMET01271 | |
| 0.108 | 0.067 | 0.108 | 5 Hydroxytryptamine 3A agonist | |||
| 0.094 | 0.054 | 0.118 | Potassium channel activator | 0.118 0.034 DBMET00166 | DBMET00166 | |
| 0.086 | 0.046 | 0.086 | Transforming growth factor beta 3 antagonist | |||
| 0.044 | 0.005 | 0.044 | Hexokinase stimulant | 0.04 0.005 DBMET00167 0.031 0.008 DBMET01272 | ||
| 0.26 | 0.222 | 0.26 | MAP kinase 1 inhibitor | |||
| 0.077 | 0.04 | 0.077 | Glutamate (mGluR group I) antagonist | |||
| 0.097 | 0.06 | 0.1 | Lanosterol 14 alpha demethylase inhibitor | 0.1 0.056 DBMET00167 | DBMET00167 | |
| 0.07 | 0.034 | 0.07 | Janus tyrosine kinase 1 inhibitor | |||
| 0.051 | 0.016 | 0.051 | Alpha 1d adrenoreceptor agonist | |||
| 0.149 | 0.114 | 0.149 | Clk dual-specificity kinase inhibitor | |||
| 0.037 | 0.004 | 0.037 | Alpha 2a adrenoreceptor agonist | 0.016 0.014 DBMET00167 | ||
| 0.105 | 0.073 | 0.105 | MAP kinase 13 inhibitor | |||
| 0.136 | 0.104 | 0.136 | CDC-like kinase 2 inhibitor | |||
| 0.036 | 0.004 | 0.036 | Sodium/hydrogen exchanger inhibitor | 0.026 0.005 DBMET00166 0.022 0.007 DBMET00167 0.018 0.011 DBMET01271 0.021 0.008 DBMET01272 | ||
| 0.06 | 0.029 | 0.06 | Cannabinoid CB2 receptor antagonist | |||
| 0.061 | 0.031 | 0.07 | GABA receptor antagonist | 0.052 0.042 DBMET00166 0.068 0.026 DBMET00167 0.07 0.026 DBMET01271 0.055 0.037 DBMET01272 | DBMET01271 | |
| 0.079 | 0.049 | 0.079 | CYP2A6 inhibitor | |||
| 0.191 | 0.162 | 0.191 | Gastrin inhibitor | |||
| 0.124 | 0.096 | 0.142 | CC chemokine 6 receptor antagonist | 0.126 0.085 DBMET01272 0.142 0.035 DBMET01273 | DBMET01273 | |
| 0.129 | 0.102 | 0.129 | Tyrosine kinase inhibitor | |||
| 0.053 | 0.029 | 0.053 | Bromodomain-containing protein 3 inhibitor | |||
| 0.077 | 0.054 | 0.077 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.053 | 0.03 | 0.053 | Alpha 1b adrenoreceptor agonist | |||
| 0.091 | 0.069 | 0.091 | Phosphodiesterase 7B inhibitor | |||
| 0.055 | 0.035 | 0.189 | Prostaglandin antagonist | 0.054 0.036 DBMET00167 0.189 0.007 DBMET01272 | DBMET01272 | |
| 0.046 | 0.027 | 0.05 | Glutamate (mGluR group III) agonist | 0.05 0.024 DBMET00167 0.049 0.024 DBMET01272 | DBMET00167 | |
| 0.039 | 0.022 | 0.039 | Growth hormone secretagogue receptor antagonist | |||
| 0.165 | 0.152 | 0.165 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.035 | 0.024 | 0.035 | Glycine transporter 1 inhibitor | |||
| 0.028 | 0.017 | 0.028 | Hedgehog signaling activator | |||
| 0.059 | 0.047 | 0.059 | Transcription factor AP-1 inhibitor | |||
| 0.063 | 0.053 | 0.063 | MAP kinase kinase 10 inhibitor | |||
| 0.02 | 0.011 | 0.02 | Alpha 2c adrenoreceptor agonist | |||
| 0.098 | 0.089 | 0.12 | Nav1.5 sodium channel blocker | 0.12 0.055 DBMET00167 | DBMET00167 | |
| 0.053 | 0.045 | 0.053 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.052 | 0.045 | 0.053 | Phosphodiesterase II inhibitor | 0.053 0.043 DBMET00167 | DBMET00167 | |
| 0.032 | 0.025 | 0.032 | Transforming growth factor beta 2 antagonist | |||
| 0.063 | 0.057 | 0.063 | ZAP-70 protein tyrosine kinase inhibitor | 0.063 0.057 DBMET00167 | ||
| 0.07 | 0.064 | 0.07 | Fibroblast growth factor 3 antagonist | |||
| 0.035 | 0.03 | 0.072 | Factor X inhibitor | 0.072 0.015 DBMET00166 0.051 0.021 DBMET01271 | DBMET00166 | |
| 0.052 | 0.046 | 0.052 | Potassium channel Kv1.5 blocker | |||
| 0.106 | 0.101 | 0.106 | Tyrosine-protein kinase receptor antagonist | |||
| 0.11 | 0.106 | 0.11 | Protein kinase C nu inhibitor | |||
| 0.012 | 0.009 | 0.012 | Glucose-dependent insulinotropic receptor antagonist | |||
| 0.034 | 0.032 | 0.041 | ATM kinase inhibitor | 0.041 0.015 DBMET00167 | DBMET00167 | |
| 0.06 | 0.06 | 0.079 | Potassium channel large-conductance Ca-activated activator | 0.079 0.035 DBMET01272 | DBMET01272 | |
| 0.067 | 0.068 | 0.258 | CC chemokine receptor antagonist | 0.258 0.007 DBMET00166 0.103 0.033 DBMET01271 | DBMET00166 | |
| 0.036 | 0.038 | 0.067 | Glucagon-like peptide 1 receptor antagonist | 0.037 0.034 DBMET00167 0.067 0.007 DBMET01272 | DBMET01272 | |
| 0.042 | 0.044 | 0.063 | Benzodiazepine inverse agonist | 0.053 0.021 DBMET00166 0.063 0.013 DBMET00167 0.058 0.016 DBMET01271 0.045 0.035 DBMET01272 | DBMET00167 | |
| 0.081 | 0.085 | 0.243 | Chemokine receptor antagonist | 0.243 0.012 DBMET00166 0.11 0.055 DBMET01271 | DBMET00166 | |
| 0.025 | 0.032 | 0.032 | MAP3K8 inhibitor | 0.032 0.015 DBMET00166 | DBMET00166 | |
| 0.01 | 0.02 | 0.018 | 5 Lipoxygenase activating protein inhibitor | 0.018 0.005 DBMET00167 | DBMET00167 | |
| 0.077 | 0.092 | 0.122 | DNA directed RNA polymerase inhibitor | 0.122 0.036 DBMET00166 0.091 0.068 DBMET01271 | DBMET00166 | |
| 0.039 | 0.055 | 0.103 | Thromboxane antagonist | 0.076 0.022 DBMET00167 0.103 0.01 DBMET01272 | DBMET01272 | |
| 0.053 | 0.07 | 0.064 | Syk tyrosine kinase inhibitor | 0.064 0.056 DBMET00167 | DBMET00167 | |
| 0.053 | 0.07 | 0.065 | Bcl-xL inhibitor | 0.065 0.028 DBMET00167 0.059 0.044 DBMET01271 0.057 0.051 DBMET01272 | DBMET00167 | |
| 0.043 | 0.062 | 0.053 | EphB4 antagonist | 0.053 0.047 DBMET00167 | DBMET00167 | |
| 0.045 | 0.067 | 0.061 | Dihydroorotate oxidase inhibitor | 0.061 0.028 DBMET01272 | DBMET01272 | |
| 0.031 | 0.058 | 0.081 | Thromboxane A2 antagonist | 0.066 0.024 DBMET00167 0.081 0.014 DBMET01272 | DBMET01272 | |
| 0.027 | 0.055 | 0.042 | Factor Xa inhibitor | 0.042 0.035 DBMET00166 | DBMET00166 | |
| 0.026 | 0.055 | 0.04 | Vascular adhesion protein 1 inhibitor | 0.04 0.025 DBMET00167 | DBMET00167 | |
| 0.007 | 0.043 | 0.111 | Prostaglandin EP1 antagonist | 0.111 0.004 DBMET01272 | DBMET01272 | |
| 0.029 | 0.066 | 0.041 | Stearoyl-CoA desaturase inhibitor | 0.041 0.036 DBMET00167 | DBMET00167 | |
| 0.03 | 0.067 | 0.107 | AMPA receptor antagonist | 0.043 0.039 DBMET00167 0.107 0.01 DBMET01272 | DBMET01272 | |
| 0.032 | 0.071 | 0.045 | Dihydroorotate dehydrogenase inhibitor | 0.045 0.043 DBMET01272 | DBMET01272 | |
| 0.012 | 0.052 | 0.073 | Kynurenine 3 monooxygenase inhibitor | 0.073 0.004 DBMET01272 | DBMET01272 | |
| 0.006 | 0.046 | 0.017 | Egl nine homolog 1 inhibitor | 0.017 0.007 DBMET01272 | DBMET01272 | |
| 0.016 | 0.057 | 0.042 | Protocollagen prolyl hydroxylase inhibitor | 0.042 0.007 DBMET01272 | DBMET01272 | |
| 0.057 | 0.102 | 0.118 | Keratolytic | 0.118 0.022 DBMET01272 | DBMET01272 | |
| 0.07 | 0.117 | 0.087 | CC chemokine 5 receptor agonist | 0.087 0.043 DBMET00166 | DBMET00166 | |
| 0.134 | 0.181 | 0.426 | Tumour necrosis factor alpha release inhibitor | 0.426 0.023 DBMET00166 0.353 0.037 DBMET01271 0.399 0.027 DBMET01273 | DBMET00166 | |
| 0.017 | 0.067 | 0.035 | Purinergic P2Y14 antagonist | 0.035 0.015 DBMET01272 | DBMET01272 | |
| 0.029 | 0.08 | 0.18 | Prostaglandin E2 antagonist | 0.18 0.006 DBMET01272 | DBMET01272 | |
| 0.061 | 0.111 | 0.094 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.094 0.044 DBMET01272 | DBMET01272 | |
| 0.059 | 0.112 | 0.073 | Viral attachment inhibitor | 0.073 0.066 DBMET00166 | DBMET00166 | |
| 0.02 | 0.074 | 0.036 | Urate transporter 1 inhibitor | 0.036 0.03 DBMET01272 | DBMET01272 | |
| 0.008 | 0.064 | 0.024 | Prostaglandin H2 antagonist | 0.024 0.019 DBMET01272 | DBMET01272 | |
| 0.046 | 0.104 | 0.17 | Nav1.8 sodium channel blocker | 0.17 0.011 DBMET01272 | DBMET01272 | |
| 0.044 | 0.102 | 0.083 | Glutamate receptor agonist | 0.083 0.05 DBMET01272 | DBMET01272 | |
| 0.041 | 0.101 | 0.068 | Prostaglandin-E synthase inhibitor | 0.068 0.052 DBMET01272 | DBMET01272 | |
| 0.071 | 0.137 | 0.121 | Interleukin 1b antagonist | 0.121 0.062 DBMET01272 | DBMET01272 | |
| 0.037 | 0.104 | 0.064 | HIV-1 reverse transcriptase inhibitor | 0.064 0.055 DBMET00166 | DBMET00166 | |
| 0.033 | 0.102 | 0.056 | Cytokine production stimulant | 0.056 0.017 DBMET01273 | DBMET01273 | |
| 0.013 | 0.094 | 0.03 | LFA antagonist | 0.03 0.016 DBMET01272 | DBMET01272 | |
| 0.214 | 0.3 | 0.272 | Caspase 9 stimulant | 0.272 0.226 DBMET01273 | DBMET01273 | |
| 0.027 | 0.117 | 0.053 | H+/K+-transporting ATPase inhibitor | 0.053 0.033 DBMET00166 | DBMET00166 | |
| 0.079 | 0.188 | 0.288 | Anticoagulant | 0.288 0.03 DBMET00166 0.266 0.035 DBMET01271 0.223 0.046 DBMET01273 | DBMET00166 | |
| 0.08 | 0.195 | 0.146 | Diuretic | 0.146 0.081 DBMET01272 | DBMET01272 | |
| 0.049 | 0.165 | 0.117 | Platelet activating factor antagonist | 0.117 0.065 DBMET00166 | DBMET00166 | |
| 0.047 | 0.173 | 0.281 | Bronchodilator | 0.172 0.024 DBMET00166 0.098 0.066 DBMET00167 0.281 0.01 DBMET01271 | DBMET01271 | |
| 0.017 | 0.144 | 0.056 | Prostaglandin EP2 antagonist | 0.056 0.045 DBMET01272 | DBMET01272 | |
| 0.038 | 0.169 | 0.12 | Protein kinase (CK2) inhibitor | 0.12 0.048 DBMET01272 | DBMET01272 | |
| 0.024 | 0.164 | 0.066 | Nitric oxide donor | 0.066 0.038 DBMET01273 | DBMET01273 | |
| 0.007 | 0.152 | 0.042 | Plasma kallikrein inhibitor | 0.042 0.016 DBMET00166 0.03 0.027 DBMET01271 | DBMET00166 | |
| 0.041 | 0.188 | 0.083 | 5-Lipoxygenase inhibitor | 0.083 0.078 DBMET01271 | DBMET01271 | |
| 0.007 | 0.157 | 0.042 | Sodium/glucose cotransporter 2 inhibitor | 0.042 0.008 DBMET01273 | DBMET01273 | |
| 0.039 | 0.189 | 0.134 | Protein kinase (CK2) alpha inhibitor | 0.134 0.052 DBMET01272 | DBMET01272 | |
| 0.109 | 0.26 | 0.516 | Hypoglycemic | 0.182 0.131 DBMET00167 0.182 0.132 DBMET01271 0.218 0.097 DBMET01272 0.516 0.014 DBMET01273 | DBMET01273 | |
| 0.018 | 0.178 | 0.071 | Kallikrein inhibitor | 0.071 0.018 DBMET00166 0.056 0.026 DBMET01271 | DBMET00166 | |
| 0.087 | 0.248 | 0.153 | Antiamyloidogenic | 0.153 0.144 DBMET01273 | DBMET01273 | |
| 0.035 | 0.211 | 0.103 | Alcohol dehydrogenase inhibitor | 0.103 0.049 DBMET01272 | DBMET01272 | |
| 0.103 | 0.29 | 0.229 | Superoxide dismutase inhibitor | 0.229 0.09 DBMET01272 | DBMET01272 | |
| 0.02 | 0.212 | 0.084 | MAP kinase 11 inhibitor | 0.084 0.045 DBMET00166 | DBMET00166 | |
| 0.021 | 0.223 | 0.084 | Leukotriene synthesis inhibitor | 0.08 0.038 DBMET00167 0.084 0.035 DBMET01273 | DBMET01273 | |
| 0.056 | 0.26 | 0.185 | Cell adhesion inhibitor | 0.185 0.029 DBMET01273 | DBMET01273 | |
| 0.043 | 0.253 | 0.231 | AMP-activated protein kinase stimulant | 0.231 0.008 DBMET01273 | DBMET01273 | |
| 0.126 | 0.344 | 0.303 | Histamine release inhibitor | 0.303 0.122 DBMET01272 | DBMET01272 | |
| 0.023 | 0.246 | 0.131 | Factor IXa inhibitor | 0.128 0.005 DBMET00166 0.131 0.005 DBMET01271 0.065 0.023 DBMET01273 | DBMET01271 | |
| 0.017 | 0.254 | 0.054 | Aconitate hydratase inhibitor | 0.054 0.032 DBMET01272 | DBMET01272 | |
| 0.075 | 0.313 | 0.127 | Interferon gamma antagonist | 0.127 0.117 DBMET01273 | DBMET01273 | |
| 0.008 | 0.247 | 0.034 | Oxytocin antagonist | 0.034 0.033 DBMET00166 | DBMET00166 | |
| 0.021 | 0.261 | 0.058 | Glucose-6-phosphate translocase inhibitor | 0.058 0.026 DBMET01273 | DBMET01273 | |
| 0.013 | 0.261 | 0.057 | NMDA receptor glycine site agonist | 0.057 0.049 DBMET01272 | DBMET01272 | |
| 0.006 | 0.275 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.016 DBMET01273 | DBMET01273 | |
| 0.032 | 0.307 | 0.131 | Uric acid excretion stimulant | 0.131 0.031 DBMET01272 0.093 0.061 DBMET01273 | DBMET01272 | |
| 0.09 | 0.37 | 0.525 | Antithrombotic | 0.525 0.026 DBMET01273 | DBMET01273 | |
| 0.02 | 0.302 | 0.056 | NMDA receptor agonist | 0.056 0.054 DBMET01272 | DBMET01272 | |
| 0.063 | 0.347 | 0.149 | DNA repair enzyme inhibitor | 0.149 0.033 DBMET01273 | DBMET01273 | |
| 0.093 | 0.379 | 0.468 | Immunomodulator | 0.224 0.138 DBMET00167 0.468 0.028 DBMET01273 | DBMET01273 | |
| 0.001 | 0.287 | 0.01 | Insulin like growth factor 3 antagonist | 0.01 0.003 DBMET01272 | DBMET01272 | |
| 0.008 | 0.304 | 0.152 | Factor XIa inhibitor | 0.152 0.004 DBMET00166 0.134 0.004 DBMET01271 | DBMET00166 | |
| 0.035 | 0.359 | 0.108 | NADH dehydrogenase inhibitor | 0.108 0.037 DBMET01273 | DBMET01273 | |
| 0.04 | 0.401 | 0.221 | Hypolipemic | 0.221 0.081 DBMET01273 | DBMET01273 | |
| 0.021 | 0.401 | 0.106 | Topoisomerase II inhibitor | 0.106 0.08 DBMET01273 | DBMET01273 | |
| 0.006 | 0.396 | 0.034 | Catechol O-methyltransferase inhibitor | 0.034 0.021 DBMET00166 0.03 0.028 DBMET01271 | DBMET00166 | |
| 0.041 | 0.433 | 0.325 | Platelet adhesion inhibitor | 0.325 0.026 DBMET01273 | DBMET01273 | |
| 0.02 | 0.436 | 0.08 | Cell adhesion molecule inhibitor | 0.08 0.053 DBMET01273 | DBMET01273 | |
| 0.045 | 0.496 | 0.186 | NOS3 expression enhancer | 0.186 0.047 DBMET01273 | DBMET01273 | |
| 0.004 | 0.465 | 0.056 | Factor XI inhibitor | 0.056 0.008 DBMET00166 0.045 0.012 DBMET01271 | DBMET00166 | |
| 0.005 | 0.479 | 0.032 | Nicotinic acid receptor 2 agonist | 0.032 0.031 DBMET01272 | DBMET01272 | |
| 0.043 | 0.529 | 0.307 | Transcription factor NF kappa B inhibitor | 0.307 0.091 DBMET01273 | DBMET01273 | |
| 0.026 | 0.529 | 0.153 | Toll-Like receptor 4 antagonist | 0.153 0.019 DBMET01273 | DBMET01273 | |
| 0.012 | 0.537 | 0.125 | Topoisomerase I inhibitor | 0.125 0.053 DBMET01273 | DBMET01273 | |
| 0.009 | 0.564 | 0.077 | Protein 50S ribosomal subunit inhibitor | 0.077 0.021 DBMET01273 | DBMET01273 | |
| 0.015 | 0.599 | 0.26 | Immunostimulant | 0.26 0.092 DBMET01273 | DBMET01273 | |
| 0.01 | 0.617 | 0.054 | Heparanase inhibitor | 0.054 0.035 DBMET01273 | DBMET01273 | |
| 0.014 | 0.641 | 0.351 | Free radical scavenger | 0.351 0.039 DBMET01273 | DBMET01273 | |
| 0.018 | 0.658 | 0.265 | Vasodilator | 0.265 0.062 DBMET00166 0.204 0.101 DBMET01271 0.193 0.11 DBMET01273 | DBMET00166 | |
| 0.011 | 0.69 | 0.196 | Platelet antagonist | 0.196 0.104 DBMET01273 | DBMET01273 | |
| 0.039 | 0.73 | 0.312 | Apoptosis antagonist | 0.312 0.078 DBMET01273 | DBMET01273 | |
| 0.028 | 0.722 | 0.305 | Hepatoprotectant | 0.305 0.028 DBMET01273 | DBMET01273 | |
| 0.031 | 0.734 | 0.402 | Apoptosis agonist | 0.402 0.112 DBMET01273 | DBMET01273 | |
| 0.02 | 0.738 | 0.354 | Immunosuppressant | 0.354 0.084 DBMET01273 | DBMET01273 | |
| 0.016 | 0.748 | 0.381 | Antibacterial | 0.381 0.086 DBMET01273 | DBMET01273 | |
| 0.01 | 0.749 | 0.175 | Thrombolytic | 0.175 0.065 DBMET01273 | DBMET01273 | |
| 0.067 | 0.834 | 0.462 | Calcium channel L-type activator | 0.462 0.045 DBMET00167 0.447 0.052 DBMET01271 | DBMET00167 | |
| 0.015 | 0.786 | 0.055 | Adenine nucleotide translocase inhibitor | 0.055 0.04 DBMET01273 | DBMET01273 | |
| 0.009 | 0.802 | 0.235 | Nitric oxide antagonist | 0.235 0.056 DBMET01273 | DBMET01273 | |
| 0.007 | 0.808 | 0.345 | Antioxidant | 0.345 0.048 DBMET01273 | DBMET01273 | |
| 0.004 | 0.866 | 0.252 | Selectin antagonist | 0.252 0.008 DBMET01273 | DBMET01273 | |
| 0.008 | 0.875 | 0.427 | Angiogenesis stimulant | 0.427 0.018 DBMET01273 | DBMET01273 | |
| 0.018 | 0.902 | 0.085 | Transcription factor NF kappa B stimulant | 0.085 0.059 DBMET01273 | DBMET01273 | |
| 0.033 | 0.946 | 0.413 | Interleukin 2 agonist | 0.413 0.024 DBMET01273 | DBMET01273 | |
| 0.005 | 0.945 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.022 DBMET01273 | DBMET01273 | |
| 0.003 | 0.978 | 0.051 | Antibiotic Aminoglycoside-like | 0.051 0.013 DBMET01273 | DBMET01273 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |